Drug
Part 1
Part 1: highest development phase Phase 1, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Part 1 NCT04942054 | Phase 1 | HER2-negative Breast Cancer |
Latest
No recent events.
Follow Part 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.